Contact Us   |   Print Page   |   Sign In   |   Join
News and Press: Industry News

VC Investing Remains Strong for Midwest Life Sciences Firms

Monday, February 22, 2016   (0 Comments)
Posted by: Kate Oesterle
Share |

Elevated by a couple of major investments, venture capital investing in Michigan life sciences companies in 2015 equaled the dollar value from the prior year with a high number of deals.

Venture capital investors put $131.73 million into 16 deals in Michigan last year, which compares to $131.7 million in 11 deals in 2014, according to an annual report by BioEnterprise Corp., a Cleveland-based initiative that tracks investments in health care and life sciences firms across the Midwest.

The last two years were the best ever for venture capital investing in Michigan-based life sciences companies. The year included major fundraising rounds such as the $39.5 million invested in September in Plymouth-based Delphinus Technologies Inc., the developer of a three-dimensional imaging device to screen for breast cancer.

Read more.

Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal